Acute intermittent porphyria (AIP) is an inborn error of metabolism inherited via a fully identified autosomal dominant gene. The porphyrias, a group of diseases ...
Givlaari (givosiran) is a prescription drug approved to treat acute hepatic porphyria (AHP). Givlaari comes as an injection given under the skin by a healthcare provider. Specifically, Givlaari is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results